Forming cross-linked peptidoglycan from synthetic gram-negative lipid II

Matthew D. Lebar, Tania Lupoli, Hirokazu Tsukamoto, Janine M. May, Suzanne Walker, Daniel Kahne

Research output: Contribution to journalArticle

Abstract

The bacterial cell wall precursor, Lipid II, has a highly conserved structure among different organisms except for differences in the amino acid sequence of the peptide side chain. Here, we report an efficient and flexible synthesis of the canonical Lipid II precursor required for the assembly of Gram-negative peptidoglycan (PG). We use a rapid LC/MS assay to analyze PG glycosyltransfer (PGT) and transpeptidase (TP) activities of Escherichia coli penicillin binding proteins PBP1A and PBP1B and show that the native m-DAP residue in the peptide side chain of Lipid II is required in order for TP-catalyzed peptide cross-linking to occur in vitro. Comparison of PG produced from synthetic canonical E. coli Lipid II with PG isolated from E. coli cells demonstrates that we can produce PG in vitro that resembles native structure. This work provides the tools necessary for reconstituting cell wall synthesis, an essential cellular process and major antibiotic target, in a purified system.

Original languageEnglish (US)
Pages (from-to)4632-4635
Number of pages4
JournalJournal of the American Chemical Society
Volume135
Issue number12
DOIs
StatePublished - Mar 27 2013

Fingerprint

Peptidoglycan
Lipids
Escherichia coli
Peptides
Cell Wall
Cells
Peptidyl Transferases
Penicillin-Binding Proteins
Escherichia coli Proteins
Antibiotics
Amino acids
Amino Acid Sequence
Assays
Anti-Bacterial Agents
Amino Acids
muramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenol
In Vitro Techniques

ASJC Scopus subject areas

  • Catalysis
  • Chemistry(all)
  • Biochemistry
  • Colloid and Surface Chemistry

Cite this

Forming cross-linked peptidoglycan from synthetic gram-negative lipid II. / Lebar, Matthew D.; Lupoli, Tania; Tsukamoto, Hirokazu; May, Janine M.; Walker, Suzanne; Kahne, Daniel.

In: Journal of the American Chemical Society, Vol. 135, No. 12, 27.03.2013, p. 4632-4635.

Research output: Contribution to journalArticle

Lebar, Matthew D. ; Lupoli, Tania ; Tsukamoto, Hirokazu ; May, Janine M. ; Walker, Suzanne ; Kahne, Daniel. / Forming cross-linked peptidoglycan from synthetic gram-negative lipid II. In: Journal of the American Chemical Society. 2013 ; Vol. 135, No. 12. pp. 4632-4635.
@article{3b47cbd80cfa41f1ae5e85106493e3dc,
title = "Forming cross-linked peptidoglycan from synthetic gram-negative lipid II",
abstract = "The bacterial cell wall precursor, Lipid II, has a highly conserved structure among different organisms except for differences in the amino acid sequence of the peptide side chain. Here, we report an efficient and flexible synthesis of the canonical Lipid II precursor required for the assembly of Gram-negative peptidoglycan (PG). We use a rapid LC/MS assay to analyze PG glycosyltransfer (PGT) and transpeptidase (TP) activities of Escherichia coli penicillin binding proteins PBP1A and PBP1B and show that the native m-DAP residue in the peptide side chain of Lipid II is required in order for TP-catalyzed peptide cross-linking to occur in vitro. Comparison of PG produced from synthetic canonical E. coli Lipid II with PG isolated from E. coli cells demonstrates that we can produce PG in vitro that resembles native structure. This work provides the tools necessary for reconstituting cell wall synthesis, an essential cellular process and major antibiotic target, in a purified system.",
author = "Lebar, {Matthew D.} and Tania Lupoli and Hirokazu Tsukamoto and May, {Janine M.} and Suzanne Walker and Daniel Kahne",
year = "2013",
month = "3",
day = "27",
doi = "10.1021/ja312510m",
language = "English (US)",
volume = "135",
pages = "4632--4635",
journal = "Journal of the American Chemical Society",
issn = "0002-7863",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Forming cross-linked peptidoglycan from synthetic gram-negative lipid II

AU - Lebar, Matthew D.

AU - Lupoli, Tania

AU - Tsukamoto, Hirokazu

AU - May, Janine M.

AU - Walker, Suzanne

AU - Kahne, Daniel

PY - 2013/3/27

Y1 - 2013/3/27

N2 - The bacterial cell wall precursor, Lipid II, has a highly conserved structure among different organisms except for differences in the amino acid sequence of the peptide side chain. Here, we report an efficient and flexible synthesis of the canonical Lipid II precursor required for the assembly of Gram-negative peptidoglycan (PG). We use a rapid LC/MS assay to analyze PG glycosyltransfer (PGT) and transpeptidase (TP) activities of Escherichia coli penicillin binding proteins PBP1A and PBP1B and show that the native m-DAP residue in the peptide side chain of Lipid II is required in order for TP-catalyzed peptide cross-linking to occur in vitro. Comparison of PG produced from synthetic canonical E. coli Lipid II with PG isolated from E. coli cells demonstrates that we can produce PG in vitro that resembles native structure. This work provides the tools necessary for reconstituting cell wall synthesis, an essential cellular process and major antibiotic target, in a purified system.

AB - The bacterial cell wall precursor, Lipid II, has a highly conserved structure among different organisms except for differences in the amino acid sequence of the peptide side chain. Here, we report an efficient and flexible synthesis of the canonical Lipid II precursor required for the assembly of Gram-negative peptidoglycan (PG). We use a rapid LC/MS assay to analyze PG glycosyltransfer (PGT) and transpeptidase (TP) activities of Escherichia coli penicillin binding proteins PBP1A and PBP1B and show that the native m-DAP residue in the peptide side chain of Lipid II is required in order for TP-catalyzed peptide cross-linking to occur in vitro. Comparison of PG produced from synthetic canonical E. coli Lipid II with PG isolated from E. coli cells demonstrates that we can produce PG in vitro that resembles native structure. This work provides the tools necessary for reconstituting cell wall synthesis, an essential cellular process and major antibiotic target, in a purified system.

UR - http://www.scopus.com/inward/record.url?scp=84875694776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875694776&partnerID=8YFLogxK

U2 - 10.1021/ja312510m

DO - 10.1021/ja312510m

M3 - Article

VL - 135

SP - 4632

EP - 4635

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

SN - 0002-7863

IS - 12

ER -